CA
NZ
UK
AU
IND
US
Market Movers:On Monday, the top gainers were GSI Technology, Inc. (+155.31%), followed by Replimune Group, Inc. (+98.78%). On the contrary United Homes Group, Inc (-52.46%), and Perspective Therapeutics, Inc. (-28.95%) declined the most the same day.
Tata Consultancy Services (TCS) (BSE:532540, NSE:TCS), a global IT services and consulting company, and Box, Inc. (NYSE:BOX), a leading Intelligent Content Management (ICM) platform, announced a strategic partnership to deliver specialized, industry-focused services worldwide. The collaboration seeks to help organizations extract value from unstructured …
ASE Technology Holding Co., Ltd. (NYSE:ASX, TAIEX: 3711) and Analog Devices, Inc. (NASDAQ: ADI) have announced a strategic collaboration in Penang, Malaysia, formalized through a binding Memorandum of Understanding. The agreement outlines ASE’s intention to acquire 100% of Analog Devices Sdn. Bhd., including its …
JPMorgan Chase & Co.has increased its target price forFord Motor Company (NYSE:F)fromUSD 13.00 to USD 14.00, according to a research report issued Monday. The brokerage maintained an“overweight”rating on the auto manufacturer’s stock. The revised target suggests a potential upside of approximately16.62%from Ford’s most recent …
Market Movers:On Friday, the top gainers were Artiva Biotherapeutics, Inc. (+116.97%), followed by Artiva Biotherapeutics, Inc. (+52.52%). On the contrary American Rebel Holdings, Inc. (-38.76%), and Sensei Biotherapeutics, Inc. (-33.43%) declined the most the same day.
GE Aerospace (NYSE:GE) received an upward revision in its price target from Royal Bank of Canada, which increased its estimate fromUSD 300.00 to USD 340.00, as per a report released on Friday by MarketScreener. The firm maintained an“Outperform”rating on the stock. The new target …
Pfizer Inc. (NYSE:PFE) has released updated follow-up results from the Phase 2 PHAROS trial, evaluating the combination of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for adults with metastatic non-small cell lung cancer (mNSCLC) carrying the BRAF V600E mutation. In treatment-naïve participants, median overall survival (OS) …
Overview:The three major US stock indexes ended the week in a state of flux, oscillating between gains and losses as market participants wrestled with two primary concerns: persistent worries over regional bank health and credit risks, counterbalanced by improved sentiment stemming from more measured …
Market Movers:On Thursday, the top gainers were Praxis Precision Medicines, Inc. (+183.71%), followed by rYojbaba Co., Ltd. (+119.35%). On the contrary American Battery Technology Company (-36.65%), and Solana Company. (-36.49%) declined the most the same day.
Microsoft (NASDAQ:MSFT) has seen a series of upward revisions in analyst price targets following recent earnings performance. Mizuho raised its target price from USD 625 to USD 640 in its latest report, maintaining an “Outperform” rating. This implies a potential upside of around 25% …
Please wait processing your request...